Global, Oncolytic Virus Therapy Research Report 2024: Market to Reach $53.06 Billion by 2028, Driven by Strategic Partnerships and Rising Awareness
March 04, 2024 11:02 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
Global Oncolytic Virus Therapy Market to Reach Value of USD 2,041.05 Million by 2032 | Emergen Research
November 02, 2023 09:30 ET
|
Emergen Research
Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The global oncolytic virus therapy market size is expected to reach USD 2,041.05 Million at a steady CAGR of 23.9% in 2032, according to latest analysis...
Global Oncolytic Virus Therapy Market Trends and Opportunities 2023-2027: Insights for HSV-based Oncolytic Virus, Adenovirus-based Oncolytic Virus, Reovirus, Poxviruses, NDV, and Other Therapy Types
November 01, 2023 08:08 ET
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market 2023" report has been added to ResearchAndMarkets.com's offering. The global oncolytic virus therapy market is...
Global T-Cell Immunotherapy Market Report 2023-2028: Increasing Developments in CAR T-Cell Therapy for Solid Tumors Fuels Growth
June 01, 2023 05:18 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Immunotherapy Market (2023-2028) by Therapy Type, Mechanism of Action, Product Class, Indication, Modality, and Geography, Competitive...
Global Oncolytic Virus Therapy Market Report 2023: Increase in Clinical Trials and Approval of New Virus Therapies Boosts Growth
May 11, 2023 07:33 ET
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook to 2035" report has been added to ResearchAndMarkets.com's offering.The global oncolytic virus therapy...
Insights on the Oncolytic Virus Immunotherapy Global Market to 2028 - Featuring Key Players AdCure Bio, BioVex, Calidi Biotherapeutics, Takara Bio and Others
December 13, 2022 06:08 ET
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market and Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The global...
Global T-Cell Immunotherapy Market Report to 2027 - Featuring Atara Biotherapeutics, Autolus and bluebird bio Among Others
July 21, 2022 07:18 ET
|
Research and Markets
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Oncolytic Virus Therapy Market to Touch a Revenue of USD 1062.7 Million by 2028; Increasing Investments for Cancer Research and Rising Incidences of Cancer to Accelerate Market Growth
December 07, 2021 07:17 ET
|
Research Nester
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the World Health Organization (WHO), cancer-related deaths recorded close to 10 Million in the year 2020. Moreover, amongst...
Global $1060 Million Oncolytic Virus Therapy Markets Outlook 2021-2028 by Therapy Type, Virus Type, Indication, Demography, End-user
December 01, 2021 05:08 ET
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market is anticipated to garner a...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...